BioArctic AB

Jul 10, 2018

BioArctic Receives Regulatory Approval in Finland for a Clinical Study in Patients With Complete Spinal Cord Injury

Jul 09, 2018

BioArctic Announces Acceptance of BAN2401 Phase 2b Results for Oral Presentation at the AAIC 2018

Jul 05, 2018

Eisai And Biogen Announce Positive Topline Results Of The Final Analysis For BAN2401 At 18 Months

May 16, 2018

BioArctic Receives This Year's SwedenBIO Award

Apr 25, 2018

Inclusion Completed of Patients With Complete Spinal Cord Injury in the First Panel of BioArctic's Ongoing Study

Mar 21, 2018

BioArctic Receives Regulatory Approval in Norway for a Clinical Study in Patients With Complete Spinal Cord Injury

Oct 13, 2017

BioArctic's Patent for its Product Candidate Antibody BAN0805, for Parkinson's Disease, is Now Granted in Europe